| Financial Year |
March 31 2023 |
| Monetary Funds |
636,013,191.73 |
| Held-for-trading Financial Assets |
591,335,172.94 |
| Notes Receivable |
2,256,809.88 |
| Accounts Receivable |
635,859,709.24 |
| Advances to Suppliers |
13,189,555.43 |
| Other Receivables |
3,204,471.37 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
478,054,774.62 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
13,073,655.44 |
| Total Current Assets |
2,763,827,669.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
112,281,378.65 |
| Investment Properties |
-- |
| Fixed Assetes |
2,900,287,624.40 |
| Under-construction Projects |
189,696,978.59 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
173,199,094.12 |
| R&D expenses |
18,053,881.03 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
225,730,987.81 |
| Other Non-Current Assets |
18,850,495.70 |
| Sub-Total of Non-Current Assets |
3,701,295,858.37 |
| Total Assets |
6,465,123,527.82 |
| Short-Term Loans |
415,348,335.01 |
| Trading Financial liabilities |
-- |
| Notes Payable |
170,885,035.17 |
| Accounts Payable |
318,136,327.24 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
32,697,213.10 |
| Taxes Payable |
12,143,418.28 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
54,680,198.77 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
239,569,287.23 |
| Other Current Liabilities |
215,788.28 |
| Sub-Total of Current Liabilities |
1,245,556,285.81 |
| Long-term Loans |
911,649,806.03 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
38,506,088.92 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,227,695,106.91 |
| Total Liabilities |
2,473,251,392.72 |
| Paid-In Capital(Or Share Stock) |
903,579,111.00 |
| Capital Surplus |
2,954,330,656.38 |
| Surplus Reserve |
74,338,825.55 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
59,233,249.55 |
| Minority Stockholder's Interest |
390,292.62 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,991,481,842.48 |
| Owner's Equity（Stockholder's Equity） |
3,991,872,135.10 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,465,123,527.82 |
